EUVIMEDEUVIMED entdecken
Crossref

Treatment of Secondary Hyperparathyroidism and Posttransplant Tertiary Hyperparathyroidism

Caitlin E Egan, Murtaza Qazi, Joyce Lee, Yeon J Lee-Saxton, Jacques A Greenberg, Toni Beninato, Rasa Zarnegar, Thomas J Fahey, Brendan M Finnerty

Journal of Surgical Research · 2023-11 · 291 · 330-335

DOI: 10.1016/j.jss.2023.06.031 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Surgical Research, 2023-11. Verfasst von Caitlin E Egan und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, Weill Cornell Medicine, New York, New York. Electronic address: Cee9007@nyp.org. Hauptthemen laut MEDLINE: Hyperparathyroidism, Secondary. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 20 Literaturangaben. Gefördert von: American Association of Endocrine Surgeons.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION: Secondary hyperparathyroidism (sHPT) is prevalent in dialysis patients and can lead to tertiary hyperparathyroidism (tHPT) after kidney transplantation. We aimed to assess the association of pretransplant sHPT treatment on posttransplant outcomes. METHODS: We reviewed kidney transplant patients treated with parathyroidectomy or cinacalcet for sHPT. We compared patients biochemical and clinical parameters, and outcomes based on sHPT treatment. RESULTS: A total of 41 patients were included: 18 patients underwent parathyroidectomy and 23 patients received cinacalcet prior to transplantation. There were no significant differences between demographics, comorbidities, allograft characteristics or pre-sHPT intervention parathyroid hormone (PTH) and calcium levels. Patients that underwent parathyroidectomy were on dialysis for longer, although not significantly (71.9 versus 42.3 mo, P = 0.051). At time of transplantation, patients treated by parathyroidectomy had increased rates of controlled sHPT (88.9%; 16/18 versus 47.8%; 11/23, P = 0.008). Patients treated by parathyroidectomy had decreased development of tHPT (5.9%; 1/17; versus 42.1%; 8/19, P = 0.020) as well as decreased rates of posttransplant treatment with cinacalcet (11.1%; 2/18 versus 52.2%; 12/23, P = 0.008). Three patients treated with cinacalcet underwent parathyroidectomy after transplantation. Median PTH after transplant remained lower in patients treated by parathyroidectomy prior to transplant compared to those treated with cinacalcet (60.7 [interquartile range 39.7-133.4] versus 170.0 [interquartile range 128.4-292.7], P = 0.001). Allograft function and survival were similar for parathyroidectomy and cinacalcet, with median follow-up after transplantation of 56.7 and 34.2 mo, respectively. CONCLUSIONS: sHPT treated by parathyroidectomy is associated with controlled PTH levels at transplantation and decreased rates of tHPT. Long-term outcomes should be studied on a larger scale.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hyperparathyroidism, SecondaryHumansCalciumCinacalcetParathyroid HormoneParathyroidectomyRenal DialysisRetrospective Studies

Stichwörter der Autor:innen

CinacalcetKidney transplantationParathyroidectomySecondary hyperparathyroidismTertiary hyperparathyroidism

Substanzen

CalciumCinacalcetParathyroid Hormone

Autor:innen und Institutionen

  • Department of Surgery, Weill Cornell Medicine, New York, New York. Electronic address: Cee9007@nyp.org.
  • Department of Surgery, Weill Cornell Medicine, New York, New York.
  • Department of Surgery Rutgers-Cancer Institute of New Jersey, Rutgers Robert Wood Johnson Medical School, New Brunswick, New Jersey.

Förderung

  • American Association of Endocrine Surgeons

Zitieren

APA

Egan, C. E., Qazi, M., Lee, J., Lee-Saxton, Y. J., Greenberg, J. A., Beninato, T., Zarnegar, R., Fahey, T. J., & Finnerty, B. M. (2023). Treatment of Secondary Hyperparathyroidism and Posttransplant Tertiary Hyperparathyroidism. Journal of Surgical Research, 291, 330-335. https://doi.org/10.1016/j.jss.2023.06.031

Vancouver

Egan CE, Qazi M, Lee J, Lee-Saxton YJ, Greenberg JA, Beninato T, et al. Treatment of Secondary Hyperparathyroidism and Posttransplant Tertiary Hyperparathyroidism. Journal of Surgical Research. 2023;291:330-335. doi:10.1016/j.jss.2023.06.031

BibTeX
@article{Egan2023,
  author = {Egan, Caitlin E and Qazi, Murtaza and Lee, Joyce and Lee-Saxton, Yeon J and Greenberg, Jacques A and Beninato, Toni and Zarnegar, Rasa and Fahey, Thomas J and Finnerty, Brendan M},
  title = {Treatment of Secondary Hyperparathyroidism and Posttransplant Tertiary Hyperparathyroidism},
  journal = {Journal of Surgical Research},
  year = {2023},
  volume = {291},
  pages = {330--335},
  doi = {10.1016/j.jss.2023.06.031}
}
Kostenlos starten →